Conference Coverage

Joint replacement: What’s new in 2020


 

REPORTING FROM RWCS 2020

The road ahead

Hip and knee replacement is an $18 billion market today. And it’s a major growth industry: According to a recent projection, there will be 1 million total hip replacements and 4 million total knee replacements annually 10 years from now, figures four times greater than projected for 2030 in an earlier 2005 estimate. The rapid growth is coming from the expanding elderly population combined with a virtual epidemic of posttraumatic arthritis in young people – but decidedly not from patients with joint failure attributable to rheumatoid arthritis.

“Congratulations! You’ve eradicated rheumatoid arthritis from my practice,” Dr. Bugbee declared. “Most of the rheumatoid arthritis patients who come to me come because they have osteoarthritis in their joint, not because of their rheumatoid arthritis.”

He reported serving as a consultant to Orthalign, Insight Medical, and Arthrex, and receiving royalties from Smith and Nephew and Depuy.

Pages

Recommended Reading

Hemophilia carriers face elevated risk of joint comorbidities
MDedge Rheumatology
Cannabidiol may interact with rheumatologic drugs
MDedge Rheumatology
Consider centralized pain in patients with rheumatic disease
MDedge Rheumatology
Cannabinoids, stem cells lack evidence for osteoarthritis, expert says
MDedge Rheumatology
Methotrexate may affect joint erosions but not pain in patients with erosive hand OA
MDedge Rheumatology
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
MDedge Rheumatology
Tanezumab posts higher safety event rate than NSAIDs over 1 year in hip, knee OA
MDedge Rheumatology
Well-tolerated topical capsaicin formulation reduces knee OA pain
MDedge Rheumatology
Prednisolone scores for hand OA
MDedge Rheumatology
Prescription osteoarthritis relief gets OTC approval
MDedge Rheumatology